- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bioversys Ag (BIOV)
Bioversys Ag stock price live, this page displays SIX BIOV stock exchange data. View the BIOV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bioversys Ag real time stock price chart below.
What Is the Bioversys Ag Stock Price Today?
The Bioversys Ag stock price today is 24.00.
What Is the Stock Symbol for Bioversys Ag?
The stock symbol for Bioversys Ag is "BIOV."
What Stock Exchange Does Bioversys Ag Trade On?
Bioversys Ag is listed and trades on the Switzerland stock exchange.
Is Bioversys Ag a Good Stock to Buy?
Determining whether Bioversys Ag—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIOV quote. (ISIN: CH0210362643)
What Is the Bioversys Ag Stock Price Today?
The Bioversys Ag stock price today is 24.00.
What Is the Stock Symbol for Bioversys Ag?
The stock symbol for Bioversys Ag is "BIOV."
What Stock Exchange Does Bioversys Ag Trade On?
Bioversys Ag is listed and trades on the Switzerland stock exchange.
Is Bioversys Ag a Good Stock to Buy?
Determining whether Bioversys Ag—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIOV quote. (ISIN: CH0210362643)
Switzerland
Currency in CHF
24.00
-0.10(-0.41%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.60
24.20
52 wk Range
21.20
37.00
BIOV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.6024.20
52 wk Range
21.2037.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BIOV Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
56.38
Upside
+134.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Bioversys Ag receives Investment Bank Analyst Rating Update
- Investing.com
Pro - BioVaxys Issues Corporate Update
- Investing.com
- BioVaxys Issues Corporate Update
- Investing.com
- Bioversys Ag receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Bioversys Ag Company Profile
BioVersys AG, a clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria. It develops BV100 that is in Phase 3 clinical trial for carbapenem resistant Acinetobacter baumannii lung and blood stream infections; and in Phase 1 trial in patients with hepatic impairment and a bronchoalveolar lavage (BAL). The company is also developing Alpibectir that is in Phase 2a clinical trial for the treatment of pulmonary tuberculosis; BV200 to treat patients with Atopic dermatitis Staphylococcus aureus; and BV500 for non-tuberculous mycobacteria infections. It has a research and license option agreement with Shionogi & Co., Ltd. to develop novel ansamycin leads from BV500 program into clinical candidates. The company was founded in 2008 and is based in Basel, Switzerland.
Compare BIOV to Peers and Sector
Metrics to compare | BIOV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIOVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.3x | −0.7x | −0.6x | |
PEG Ratio | - | 0.00 | 0.00 | |
Price/Book | 2.0x | 1.1x | 2.6x | |
Price / LTM Sales | 107.7x | 3.1x | 3.4x | |
Upside (Analyst Target) | 156.8% | 25.6% | 44.4% | |
Fair Value Upside | Unlock | 7.4% | 6.1% | Unlock |
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 56.38
(+134.92% Upside)
Earnings
Latest Release
Dec 03, 2025
EPS / Forecast
-0.99 / --
Revenue / Forecast
300.00K / --
People Also Watch
FAQ
What Is the Bioversys Ag (BIOV) Stock Price Today?
The Bioversys Ag stock price today is 24.00
What Stock Exchange Does Bioversys Ag Trade On?
Bioversys Ag is listed and trades on the Switzerland Stock Exchange stock exchange.
What Is the Stock Symbol for Bioversys Ag?
The stock symbol for Bioversys Ag is "BIOV."
What Is the Bioversys Ag Market Cap?
As of today, Bioversys Ag market cap is 140.35M.
What Is Bioversys Ag's Earnings Per Share (TTM)?
The Bioversys Ag EPS (TTM) is -4.34.
When Is the Next Bioversys Ag Earnings Date?
Bioversys Ag will release its next earnings report on Mar 31, 2026.
From a Technical Analysis Perspective, Is BIOV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Bioversys Ag Stock Split?
Bioversys Ag has split 0 times.
How Many Employees Does Bioversys Ag Have?
Bioversys Ag has 29 employees.
What is the current trading status of Bioversys Ag (BIOV)?
As of Jan 30, 2026, Bioversys Ag (BIOV) is trading at a price of 24.00, with a previous close of 24.10. The stock has fluctuated within a day range of 23.60 to 24.20, while its 52-week range spans from 21.20 to 37.00.
What Is Bioversys Ag (BIOV) Price Target According to Analysts?
The average 12-month price target for Bioversys Ag is CHF56.38, with a high estimate of CHF70 and a low estimate of CHF40. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +134.92% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.